ALIGHT

Serial Number 88730506
Registration 6268010
700

Registration Progress

Application Filed
Dec 17, 2019
Under Examination
Jul 28, 2020
Approved for Publication
Jun 2, 2020
Published for Opposition
Jun 2, 2020
Registered
Feb 9, 2021

Basic Information

Serial Number
88730506
Registration Number
6268010
Filing Date
December 17, 2019
Registration Date
February 9, 2021
Published for Opposition
June 2, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 9, 2021
Registration
Registered
Classes
042

Rights Holder

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED

24
Address
BUILDING 730 KENT SCIENCE PARK
SITTINGBOURNE, KENT ME9 8AG
GB

Ownership History

GW Research Limited

Original Applicant
99
Cambridge GB

GW Research Limited

Owner at Publication
99
Cambridge GB

GW Research Limited

Original Registrant
99
Cambridge GB

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED

New Owner After Registration #1
24
SITTINGBOURNE, KENT GB

Legal Representation

Attorney
Michael T. Olsen

USPTO Deadlines

Next Renewal Deadline
581 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-02-09)
Due Date
February 09, 2027
Grace Period Ends
August 09, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

28 events
Date Code Type Description
Feb 24, 2025 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 15, 2021 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 15, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 15, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 15, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 28, 2021 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Feb 9, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER
Jan 8, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 7, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 6, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Jan 5, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 15, 2020 IUAF S USE AMENDMENT FILED
Dec 15, 2020 EISU I TEAS STATEMENT OF USE RECEIVED
Jul 28, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 2, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 2, 2020 PUBO A PUBLISHED FOR OPPOSITION
May 13, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 27, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 22, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 22, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 22, 2020 ALIE A ASSIGNED TO LIE
Apr 17, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 13, 2020 GNRT F NON-FINAL ACTION E-MAILED
Mar 13, 2020 CNRT R NON-FINAL ACTION WRITTEN
Mar 13, 2020 DOCK D ASSIGNED TO EXAMINER
Mar 13, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 20, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 20, 2019 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 042
Conducting clinical trials for others; conducting clinical trials for others in the field of pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing scientific information in the field of medical disorders and their treatment
First Use Anywhere: 20191200
First Use in Commerce: 20191200

Additional Information

Pseudo Mark
A LIGHT

Classification

International Classes
042